Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Cigna is raising its outlook for the year after beating the Street on both earnings and revenue in the second quarter of 2026. | Cigna is raising its outlook for the year after beating the Street on both earnings and revenue in the second quarter of 2026.
Cigna posts Q2 beat: $1.7B profit (+13%), $71.7B revenue (+6.7%), upgrades EPS guidance to $30.45. AI-personalization in customer care and Evernorth platform (+6%) offset medical cost pressure; validates tech-stack as payer competitive moat.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Cigna Expects Lower Growth in Popular GLP-1 Drug Prescriptions - Cigna Group (NYSE:CI)

Cognizant sees Q2 revenue rise 4.5%, raises FY26 EPS outlook

Cognizant Q2 revenue rises 4.5% to $5.48B

Cognizant lifts annual profit forecast on strong financial services growth

Health Care Up After Centene Earnings - Health Care Roundup

As New CEO Takes Charge, Cigna Reports $1.7 Billion Quarterly Profit

Biogen flips '26 guidance from expected decline to sales increase

Cognizant logs marginal dip in Q2 net, revenue rises 4.5% - The Economic Times

Cigna Healthcare is taking steps to significantly expand its personalized care management programs, leaning on AI to identify…

Centene reported $1.1 billion in profit for the second quarter of 2026, rebounding from a loss a year ago. | Centene reported…

Universal Health Services notched a solid second quarter and has raised its revenue guidance for the year, though it now expects…

UPDATED: July 16 at 1 p.m. ET | UnitedHealth Group boosted its outlook for the year on the back of $5.5 billion in profit for the…

The Cigna Group's Second Quarter 2026 Earnings Release Details

Cigna beat second-quarter earnings and revenue estimates, raised its 2026 profit outlook and said GLP-1 utilization growth is…